T1	Participants 73 130	overweight and obese subjects with cardiovascular disease
T2	Participants 313 407	overweight and obese subjects receiving long-term sibutramine treatment with diet and exercise
T3	Participants 631 726	9804 male and female subjects, aged 55 years or older, with a body mass index of 27-45 kg m(-2)
T4	Participants 2224 2272	obese elderly cardiovascular diseased population
